(1)
Negligible Impact of Highly Patient-Specific Decision Support for Potassium-Increasing Drug-Drug Interactions – a Cluster-Randomised Controlled Trial. Swiss Med Wkly 2019, 149 (1516), w20035. https://doi.org/10.4414/smw.2019.20035.